Skip to content

Serotonin: all studies

Page 90 of 400: studies 891 to 900 of 3,999, newest first. Back to the serotonin overview

Research

Serotonin model of schizophrenia: emerging role of glutamate mechanisms.

Brain research. Brain research reviews March 2000 George K. Aghajanian, Gerard J. Marek

The serotonin (5-HT) hypothesis of schizophrenia arose from early studies on interactions between the hallucinogenic drug LSD (D-lysergic acid diethylamide) and 5-HT in peripheral systems. More recent studies have shown that the two major classes of psychedelic hallucinogens, the indoleamines (e.g., LSD) and phenethylamines (e.g. , mescaline), produce their central effects through a common...

Effects of repeated phencyclidine treatment on serotonin transporter in rat brain.

Neuroscience Letters February 11, 2000 T Hori, S Abe, A Baba et al.

Phencyclidine (PCP) is known to be an inhibitor of serotonin (5-HT) uptake and to increase serotonergic activity. The development of tolerance to serotonergic stereotyped behaviors induced by repeated PCP treatment and changes of 5-HT transporters were examined. Backpedalling was significantly reduced in frequency following 14 days PCP treatment (7.5 mg/kg per day). Furthermore, repeated PCP...

Serotonergic deficits and impaired passive-avoidance learning in rats by MDEA: a comparison with MDMA.

Pharmacology, Biochemistry, and Behavior February 2000 Meritxell Barrionuevo, Norberto Aguirre, J D Del Río et al.

The serotonergic deficits induced by 3,4-methylenedioxyethamphetamine (MDEA, "eve"), were examined and compared with 3,4 methylenedioxymethamphetamine (MDMA, "ecstasy"). A single dose of MDEA (10, 20, or 40 mg/kg IP) induced a dose-related hyperthermia, but only the highest dose significantly reduced 5-HT content and 5-HT transporter density in the frontal cortex and in the hippocampus 7 days...

ChemInform Abstract: Synthesis and Serotonergic Activity of a Series of 2‐(N‐Benzyl)‐carboxamido‐5‐substituted‐N,N‐dimethyltryptamine Derivatives (I): Novel Antagonists for the Vascular 5‐HT1B‐Like Receptors.

ChemInform January 25, 2000 Gerard P. Moloney, Graeme R. Martin, Neil Mathews et al.

AbstractChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable via the “References” option.

Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin

Synapse 2000 Richard B Rothman, Michael H. Baumann, Christina M Dersch et al. 933 citations

A large body of evidence supports the hypothesis that mesolimbic dopamine (DA) mediates, in animal models, the reinforcing effects of central nervous system stimulants such as cocaine and amphetamine. The role DA plays in mediating amphetamine-type subjective effects of stimulants in humans remains to be established. Both amphetamine and cocaine increase norepinephrine (NE) via stimulation of...

(±)3,4-Methylenedioxymethamphetamine (‘Ecstasy’)-Induced Serotonin Neurotoxicity: Clinical Studies

Neuropsychobiology 2000 Una D. Mccann, Victoria Eligulashvili, George A. Ricaurte 192 citations

(±)3,4-Methylenedioxymethamphetamine (MDMA, ‘Ecstasy’) is a brain serotonergic neurotoxin in experimental animals, including nonhuman primates. It is also an increasingly popular recreational drug of abuse, and doses of MDMA that are used recreationally overlap with those that produce serotonin (5-HT) neurotoxicity in animals. Studies in human MDMA users probing for evidence of brain...

(±)3,4-Methylenedioxymethamphetamine (‘Ecstasy’)-Induced Serotonin Neurotoxicity: Studies in Animals

Neuropsychobiology 2000 George A. Ricaurte, Jie Yuan, Una D. Mccann 291 citations

The popular recreational drug, (±)3,4-methylenedioxymethamphetamine (MDMA; ‘Ecstasy’) is a potent and selective brain serotonin (5-HT) neurotoxin in animals. MDMA-induced 5-HT neurotoxicity can be demonstrated using a variety of neurochemical, neuroanatomical and, more recently, functional measures of 5-HT neurons. Although the neurotoxic effects of MDMA in animals are widely accepted, the...

The paradox of 5-methoxy-N,N-dimethyltryptamine: an indoleamine hallucinogen that induces stimulus control via 5-HT1A receptors.

Pharmacology, Biochemistry, and Behavior 2000 Jerrold C Winter, R A Filipink, D Timineri et al. 80 citations

Stimulus control was established in rats trained to discriminate either 5-methoxy-N,N-dimethyltryptamine (3 mg/kg) or (-)-2,5-dimethoxy-4-methylamphetamine (0.56 mg/kg) from saline. Tests of antagonism of stimulus control were conducted using the 5-HT1A antagonists (+/-)-pindolol and WAY-100635, and the 5-HT2 receptor antagonist pirenperone. In rats trained with 5-MeO-DMT, pindolol and...

Glutathione and N-Acetylcysteine Conjugates of α-Methyldopamine Produce Serotonergic Neurotoxicity: Possible Role in Methylenedioxyamphetamine-Mediated Neurotoxicity

Chemical Research in Toxicology November 19, 1999 Fengju Bai, Serrine S. Lau, Terrence J. Monks 109 citations

Direct injection of either 3,4-(+/-)-methylenedioxymethamphetamine (MDMA) or 3,4-(+/-)-methylenedioxyamphetamine (MDA) into the brain fails to reproduce the serotonergic neurotoxicity seen following peripheral administration. The serotonergic neurotoxicity of MDA and MDMA therefore appears to be dependent upon the generation of a neurotoxic metabolite, or metabolites, the identity of which...

Serotonergic receptor subtypes and hallucinogen-induced stimulus control.

Pharmacology, Biochemistry, and Behavior October 1999 Jerrold C Winter, David Fiorella, D M Timineri et al.

More than a quarter century has passed since the demonstration that indoleamine and phenethylamine hallucinogens can function as discriminative stimuli in the rat, and that serotonergic systems are critically involved. During that period our knowledge of the physiology, pharmacology, biochemistry, and molecular biology of serotonergic receptors has increased exponentially; with each advance it...